🔴 Protara Therapeutics is trading 5% down; reason unclear

Protara Therapeutics is trading 5.45% down at $3.04, with no clear catalyst identified for the September 30, 2026 decline.

• No company-specific announcement clearly linked to the decline surfaced; the latest identified company announcement was its September 8 investor-conference presentation notice.
• Major indexes were mixed to higher, offering no clear explanation. The September 29 pre-market gain also had no clearly identified catalyst.